WASHINGTON – Pharmacogenomic testing for sensitivity to the blood thinner warfarin (Coumadin) looks like a great idea to FDA (Medical Device Daily, Aug. 20, 2007), but that might not be the majority view among members of the American Association for Clinical Chemistry (AACC; Washington) if an informal and utterly unscientific poll conducted on Monday is any indication. (Medical Device Daily)

WASHINGTON – This year's annual meeting of the American Association for Clinical Chemistry (AACC; Washington) demonstrates that the clinical lab professional is no more wedded to the tried and true than any other healthcare professional. One of Sunday's presenters discussed several sources of inaccuracy in cholesterol measurements, which he blamed on the reagents used in assays that are commonly employed to determine a patient's risk of cardiovascular disease. (Medical Device Daily)

The artificial pancreas may never arrive, especially if stem cells and gene therapy ever make serious inroads on modern healthcare, but a number of parties are pressing forward with effort to put a device into play that will do a reasonable job all the same.